Skip to main content
. 2020 Dec 8;2020:3042636. doi: 10.1155/2020/3042636

Figure 1.

Figure 1

Effects of 10-HDA on the viability of human lung cancer cells. (a) A549, NCI-H460, and NCI-H23 human lung cancer cells were treated with different concentrations (1, 3, 10, 30, and 100 μM) of 10-HDA and 5-FU for 24 h. (b) IMR90 human normal lung fibroblasts, L-02 human normal liver cells, and GES-1 human gastric epithelial mucosa cells were treated with different concentrations (1, 3, 10, 30, and 100 μM) of 10-HDA and 5-FU for 24 h. (c) A549, NCI-H460, and NCI-H23 human lung cancer cells were treated with 30 μM 10-HDA and 5-FU for different time periods (3, 6, 12, 24, and 36 h). (d) IMR90 human normal lung fibroblasts, L-02 human normal liver cells, and GES-1 human gastric epithelial mucosa cells were treated with 30 μM 10-HDA and 5-FU for different time periods (3, 6, 12, 24, and 36 h). Cell viability was assessed by the CCK-8 assay. ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001 vs. the 5-FU group.